These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1792902)

  • 21. Clinical significance of morphologic classification of coronary arterial segmental stenosis due to Kawasaki disease.
    Suzuki A; Kamiya T; Ono Y; Kinoshita Y; Kawamura S; Kimura K
    Am J Cardiol; 1993 May; 71(13):1169-73. PubMed ID: 8480642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Value of multislice spiral computed tomography in finding coronary artery lesion in children with Kawasaki disease].
    Yu XY; Wang H; Hou Y; Chen R; Xing YL
    Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):896-900. PubMed ID: 17254454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effective use of echocardiography in children with Kawasaki disease.
    Scott JS; Ettedgui JA; Neches WH
    Pediatrics; 1999 Nov; 104(5):e57. PubMed ID: 10545583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Angiographic evaluation of coronary artery lesions due to Kawasaki disease-natural history and coronary artery obstruction].
    Takahashi N
    Fukuoka Igaku Zasshi; 1995 Mar; 86(3):92-8. PubMed ID: 7750895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients.
    Kato H; Sugimura T; Akagi T; Sato N; Hashino K; Maeno Y; Kazue T; Eto G; Yamakawa R
    Circulation; 1996 Sep; 94(6):1379-85. PubMed ID: 8822996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Occlusion of the right coronary artery as sequelae of Kawasaki disease: the clinical features of 9 cases.
    Takahashi N; Fukushige J; Hijii T; Igarashi H; Ooshima A; Ueda K
    Cardiology; 1995; 86(3):207-10. PubMed ID: 7614492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Kawasaki disease: new and important problems in cardiology].
    Kato H; Ichinose E
    J Cardiogr; 1983 Sep; 13(3):731-47. PubMed ID: 6678300
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of percutaneous transluminal coronary angioplasty to coronary arterial stenosis in Kawasaki disease.
    Ino T; Akimoto K; Ohkubo M; Nishimoto K; Yabuta K; Takaya J; Yamaguchi H
    Circulation; 1996 May; 93(9):1709-15. PubMed ID: 8653877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mucocutaneous lymph node syndrome: clinical, hemodynamic and angiographic features of coronary obstructive disease.
    Nakanishi T; Takao A; Nakazawa M; Endo M; Niwa K; Takahashi Y
    Am J Cardiol; 1985 Mar; 55(6):662-8. PubMed ID: 3976508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coronary heart disease in children with Kawasaki disease.
    Kato H; Koike S; Tanaka C; Yokochi K; Yoshioka F; Takeuchi S; Matsunaga S; Yokoyama T
    Jpn Circ J; 1979 May; 43(5):469-75. PubMed ID: 470108
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunohistochemical study of apparently intact coronary artery in a child after Kawasaki disease.
    Suzuki A; Miyagawa-Tomita S; Komatsu K; Nakazawa M; Fukaya T; Baba K; Yutani C
    Pediatr Int; 2004 Oct; 46(5):590-6. PubMed ID: 15491390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term outcome of coronary abnormalities in patients after Kawasaki disease.
    Fukushige J; Takahashi N; Ueda K; Hijii T; Igarashi H; Ohshima A
    Pediatr Cardiol; 1996; 17(2):71-6. PubMed ID: 8833489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kawasaki disease, myocardial infarction and coronary artery revascularization.
    Wong D; Harder J; Jadavji T
    Can J Cardiol; 2005 May; 21(7):601-4. PubMed ID: 15940359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical value of serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 for the prediction and early diagnosis of coronary artery lesion in patients with Kawasaki disease].
    Peng Q; Zhou TF; Chen CH; Hua YM; Liu HM; Hong H; Zhang LY; Wu Q
    Zhonghua Er Ke Za Zhi; 2005 Sep; 43(9):676-80. PubMed ID: 16191301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ischemic heart disease in Kawasaki disease.
    Kamiya T; Suzuki A
    Prog Clin Biol Res; 1987; 250():347-55. PubMed ID: 3423048
    [No Abstract]   [Full Text] [Related]  

  • 36. [Cardiac involvement in Kawasaki disease].
    Urcelay G; Hernández I; Farrú O; Arcil G; Godoy F
    Rev Chil Pediatr; 1989; 60(6):315-9. PubMed ID: 2520836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Risk factors for coronary artery lesions secondary to Kawasaki disease in children].
    Deng YC; Wang X; Tang XC; Huang CZ; Yang J; Mo LY
    Zhongguo Dang Dai Er Ke Za Zhi; 2015 Sep; 17(9):927-31. PubMed ID: 26412172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Indication of aortocoronary by-pass for coronary arterial obstruction due to Kawasaki disease.
    Suzuki A; Kamiya T; Ono Y; Takahashi N; Naito Y; Kou Y
    Heart Vessels; 1985 May; 1(2):94-100. PubMed ID: 3879490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultrastructural characteristics of myocardial and coronary microvascular lesions in Kawasaki disease.
    Liu AM; Ghazizadeh M; Onouchi Z; Asano G
    Microvasc Res; 1999 Jul; 58(1):10-27. PubMed ID: 10388599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complications of percutaneous transluminal coronary rotational ablation in Kawasaki disease.
    Matsui H; Yasui S; Saito S
    Pediatr Cardiol; 2000; 21(5):500-1. PubMed ID: 10982721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.